Literature DB >> 6148912

Dementia and motor neuron disease: morphometric, biochemical, and Golgi studies.

D S Horoupian, L Thal, R Katzman, R D Terry, P Davies, A Hirano, R DeTeresa, P A Fuld, C Petito, J Blass.   

Abstract

In three patients dementia without neurofibrillary tangles or Pick bodies antedated amyotrophy by several years. The motor neuron disorder in two patients was characterized by terminal bulbar symptoms; in one it was similar to classic amyotrophic lateral sclerosis. In two patients, quantitative studies of selected regions of the cortex using a computerized image analyzer disclosed, as in patients with senile dementia of Alzheimer type, a marked reduction in the number of neurons, especially those larger than 90 mu 2. The findings differed from those in Alzheimer dementia, however, in that the cells in the substantia innominata were not reduced and the levels of choline acetyltransferase and somatostatin-like immunoreactivity, determined in one patient, were within normal limits. A variable degree of sponginess of the upper layers of the cortex was attributed to attrition of pyramidal cell dendrites, observed in the one patient in whom Golgi study was successful. Because of severe degeneration of the substantia nigra in all three, the disease in these patients may represent a subset of motor neuron disease or a multisystem atrophy.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6148912     DOI: 10.1002/ana.410160306

Source DB:  PubMed          Journal:  Ann Neurol        ISSN: 0364-5134            Impact factor:   10.422


  16 in total

1.  Ubiquitin-positive intraneuronal inclusions in the extramotor cortices of presenile dementia patients with motor neuron disease.

Authors:  K Okamoto; N Murakami; H Kusaka; M Yoshida; Y Hashizume; Y Nakazato; E Matsubara; S Hirai
Journal:  J Neurol       Date:  1992-10       Impact factor: 4.849

2.  Progressive anarthria with secondary parkinsonism: a clinico-pathological case report.

Authors:  E Broussolle; M Tommasi; F Mauguière; G Chazot
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-07       Impact factor: 10.154

3.  Single photon emission computed tomography in motor neuron disease with dementia.

Authors:  H Sawada; F Udaka; Y Kishi; N Seriu; T Mezaki; M Kameyama; M Honda; M Tomonobu
Journal:  Neuroradiology       Date:  1988       Impact factor: 2.804

4.  Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis.

Authors:  I Ferrer; T Tuñón; M T Serrano; R Casas; S Alcántara; M J Zújar; R M Rivera
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-03       Impact factor: 10.154

5.  Corticobasal degeneration with neither argyrophilic inclusions nor tau abnormalities: a new subgroup?

Authors:  K Kawasaki; K Iwanaga; K Wakabayashi; M Yamada; H Nagai; J Idezuka; Y Homma; F Ikuta
Journal:  Acta Neuropathol       Date:  1996       Impact factor: 17.088

6.  Unusual case of corticobasal degeneration with tau/Gallyas-positive neuronal and glial tangles.

Authors:  D S Horoupian; P L Chu
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

7.  Topographic involvement of the striatal efferents in basal ganglia of patients with adult-onset motor neuron disease with basophilic inclusions.

Authors:  H Ito; H Kusaka; S Matsumoto; T Imai
Journal:  Acta Neuropathol       Date:  1995       Impact factor: 17.088

8.  Frontal lobe dementia and motor neuron disease.

Authors:  D Neary; J S Snowden; D M Mann; B Northen; P J Goulding; N Macdermott
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-01       Impact factor: 10.154

9.  Aetiological considerations and risk factors for multi-infarct dementia.

Authors:  J S Meyer; K L McClintic; R L Rogers; P Sims; K F Mortel
Journal:  J Neurol Neurosurg Psychiatry       Date:  1988-12       Impact factor: 10.154

10.  Dementia of frontal lobe type and motor neuron disease. A Golgi study of the frontal cortex.

Authors:  I Ferrer; C Roig; A Espino; G Peiro; X Matias Guiu
Journal:  J Neurol Neurosurg Psychiatry       Date:  1991-10       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.